By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Nanopore today said that it has raised £25 million ($41 million) in a private placement of ordinary shares.

The Oxford, UK-based nanopore sequencing firm said that it would use the funds to support further development, external validation, and production capabilities for its technology in DNA sequencing and protein analysis applications. The firm's platform technology, GridION, consists of a scalable, modular instrument and consumable cartridge.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.